What is the “True” Prevalence of Female Sexual Dysfunctions and Does the Way We Assess These Conditions Have an Impact?
Richard D. Hayes, BSc(Hons), Lorraine Dennerstein, MBBS, PhD, Catherine M. Bennett, PhD, and Christopher K. Fairley, MBBS, PhD
pages 777–787
Importance of and Satisfaction with Sex Among Men and Women Worldwide: Results of the Global Better Sex Survey
John Mulhall, MD, Rosie King, MBBS, Sidney Glina, MD, PhD, and Kyle Hvidsten, MPH
pages 788–795
The Sexual Lives of Medical Students: A Single Institution Survey
Alan W. Shindel, MD, Genoa G. Ferguson, MD, Christian J. Nelson, PhD, and Steven B. Brandes, MD
pages 796–803
Restoration of Female Genital Vasocongestive Arousal Responses in Young and Aged Rats
Rochard K.S. Beharry, Taben M. Hale, Jeremy P.W. Heaton, Rany Shamloul, and Michael A. Adams
pages 804–812
Role of Chloride Channels in the Regulation of Corpus Cavernosum Tone: A Potential Therapeutic Target for Erectile Dysfunction
Lau Lang Chu, BSc Hons, MSc, and P. Ganesan Adaikan, PhD, DSc, ACS
pages 813–821
Effect of Testosterone on Potassium Channel Opening in Human Corporal Smooth Muscle Cells
Deok Hyun Han, MD, Mee Ree Chae, MA, Jae Hun Jung, MD, Insuk So, MD, PhD, Jong Kwan Park, MD, PhD, and Sung Won Lee, MD, PhD
pages 822–832
Does Erectile Tissue Angioarchitecture Modify with Aging? An Immunohistological and Morphometric Approach
Carla Costa, PhD, and Pedro Vendeira, MD, PhD
pages 833–840
Depression in Dhat Syndrome
Vikas Dhikav, MD, Neeraj Aggarwal, MD, Supriya Gupta, MBBS, Radhika Jadhavi, MBBS, andKuljeet Singh, DM
pages 841–844
The Roles of Testosterone and Alpha-Amylase in Exercise-Induced Sexual Arousal in Women
Lisa Dawn Hamilton, BA, Emily A. Fogle, BS, and Cindy M. Meston, PhD
pages 845–853
Menstrual Cycle-Related Changes in Circulating Androgens in Healthy Women With Self-Reported Normal Sexual Function
Andrea Salonia, Marina Pontillo, Rossella E. Nappi, Giuseppe Zanni, Fabio Fabbri, Marina Scavini, Rita Daverio, Andrea Gallina, Patrizio Rigatti, Emanuele Bosi, Pier Angelo Bonini, and Francesco Montorsi
pages 854–863
“Diagnostic Investigation of the Pelvic Floor”: A Helpful Tool in the Approach in Patients with Complaints of Micturition, Defecation, and/or Sexual Dysfunction
Petra J. Voorham-van der Zalm, Guus A.B. Lycklama à Nijeholt, MD, PhD, Henk Willem Elzevier, MD, Hein Putter, MD, PhD, and Rob C.M. Pelger, MD, PhD
pages 864–871
Sexual Dysfunction and Associated Risk Factors in Women with End-Stage Renal Disease
Elife Ketta![s]()
, MSc, Filiz Çayan, MD, Erdem Akbay, MD, Ahmet K![i]()
yk![i]()
m, MD, and Selahittin Çayan, MD
pages 872–877
Determinants of Sexual Function among Women with Type 2 Diabetes in a Nigerian Population
John Olarinoye, MD, and Adebunmi Olarinoye, MD
pages 878–886
Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study
Mohammad Reza Safarinejad, MD
pages 887–897
Snoring as a Risk Factor for Sexual Dysfunction in Community Men
Viktor Hanak, MD, Debra J. Jacobson, MS, Michaela E. McGree, BS, Jennifer St. Sauver, PhD, Michael M. Lieber, MD, Eric J. Olson, MD, Virend K. Somers, MD, PhD, Naomi M. Gades, DVM, and Steven J. Jacobsen, MD, PhD
pages 898–908
The Treatment of Sleep-Related Painful Erections
Mels F. van Driel, PhD, Jack J. Beck, MD, Henk W. Elzevier, MD, Johannes H. van der Hoeven, PhD, and J.M. Nijman, PhD
pages 909–918
The Effect of Comorbidity and Socioeconomic Status on Sexual and Urinary Function and on General Health-Related Quality of Life in Men Treated with Radical Prostatectomy for Localized Prostate Cancer
Pierre I. Karakiewicz, MD, Naeem Bhojani, MD, Alfred Neugut, MD, Shahrokh F. Shariat, MD, Claudio Jeldres, MD, Markus Graefen, MD, Paul Perrotte, MD, Francois Peloquin, MD, and Michael W. Kattan, MD
pages 919–927
Male Erectile Dysfunction and Cardiovascular Disease: Is There an Intimate Nexus?
Kew-Kim Chew, MBBS, FRCPEdin, FRCPGlasg, Alexandra Bremner, BSc(Hons), GradDipAppStats, PhD, Konrad Jamrozik, MBBS, DPhil, Carolyn Earle, BSc, PgradDipHithSci, and Bronwyn Stuckey, MBBS, FRACP
pages 928–934
Combination of Alfuzosin and Tadalafil Exerts In Vitro an Additive Relaxant Effect on Human Corpus Cavernosum
Stephanie Oger, PhD, Delphine Behr-Roussel, PharmD, PhD, Diane Gorny, MSc, Jack Charles Tremeaux, MD, Michel Combes, MD, Laurent Alexandre, MD, and François Giuliano, MD, PhD
pages 935–945
The Efficacy and Safety of Udenafil, a New Selective Phosphodiesterase Type 5 Inhibitor, in Patients with Erectile Dysfunction
Jae-Seung Paick, MD, PhD, Sae Woong Kim, MD, PhD, Dae Yeol Yang, MD, PhD, Ja Jong Kim, MD, PhD, Sung Won Lee, MD, PhD, Tai Young Ahn, MD, PhD, Hyung Ki Choi, MD, PhD, Jun-Kyu Suh, MD, PhD, and Sae Chul Kim, MD, PhD
pages 946–953
Urologist Practice Patterns in the Management of Peyronie’s Disease: A Nationwide Survey
Alan W. Shindel, MD, Travis L. Bullock, MD, and Steven Brandes, MD
pages 954–964
Regarding Waldinger and Schweitzer’s “Premature Ejaculation and Pharmaceutical Company-Based Medicine: The Dapoxetine Case”
Irwin Goldstein, MD
Editor-in-Chief
pages 965–965
Premature Ejaculation and Pharmaceutical Company-Based Medicine: The Dapoxetine Case
Marcel D. Waldinger, MD, PhD, and Dave H. Schweitzer, MD, PhD
pages 966–997
The Paradox Dividing Testosterone Deficiency Symptoms and Androgen Assays: A Closer Look at the Cellular and Molecular Mechanisms of Androgen Action
Malcolm Carruthers, MD, FRCPath
pages 998–1012
Restoration of the Penis Following Amputation at Circumcision: Shaeer’s A-Y Plasty
Osama Shaeer, MD
pages 1013–1021
Male Anorgasmia Treated with Oxytocin
Waguih William IsHak, MD, FAPA, Daniel S. Berman, MD, and Anne Peters, MD
pages 1022–1024
Subarachnoid Hemorrhage as Complication of Phenylephrine Injection for the Treatment of Ischemic Priapism in a Sickle Cell Disease Patient
Hugo H. Davila, MD, Justin Parker, MD, J. Christopher Webster, MD, Jorge L. Lockhart, MD, and Rafael E. Carrion, MD
pages 1025–1028
